Contents
  • The Case for Topical Treatments
  • When Oral Treatments Shine
  • Combining Therapies

Topical vs. Oral Treatments for Onychomycosis: Which is Right for You?

Topical vs. Oral Treatments for Onychomycosis: Which is Right for You?

Why It Matters

Choosing the right treatment for onychomycosis can be daunting. Knowing the pros and cons of topical versus oral therapies can guide your decision.
Contents
  • The Case for Topical Treatments
  • When Oral Treatments Shine
  • Combining Therapies

The Case for Topical Treatments

Topical antifungals, like efinaconazole and ciclopirox, are applied directly to the nail and skin around it. They carry fewer risks of side effects compared to oral medications but may require longer treatment durations. Topicals are ideal for mild cases or for those who cannot take oral medications.

When Oral Treatments Shine

Oral antifungals, such as terbinafine and itraconazole, are often more effective for severe onychomycosis. They work throughout the body, attacking the infection from the inside. However, they can have more side effects and require monitoring, especially for liver health.
Onychomycosis is a fungal infection of the nails that can be treated with topical or oral antifungal medications.

Combining Therapies

In some cases, combining oral and topical treatments can enhance results, especially for stubborn infections. This approach may shorten treatment time and reduce the chances of recurrence. Always consult with a healthcare provider before starting combination therapy.

FAQs

Which is safer, topical or oral?

Topicals are generally safer with fewer side effects.

Is oral treatment more effective?

Oral treatments are often more effective for severe infections.

Can treatments be combined?

Yes, combining treatments may improve results.

Do oral antifungals require monitoring?

Yes, particularly for liver health.

The Bottom Line

Choose your treatment based on infection severity and personal health needs.
Consult Doctronic to find the best treatment strategy for your onychomycosis.
Additional References
  1. Elewski B, et al. J Am Acad Dermatol 2015; 73:62.
  2. Gupta AK, et al. Clin Dermatol 2013; 31:544.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.